Evidence map›Paper›PMID 32607780›Full record

ArticleEuropean journal of clinical pharmacology2020

Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan Africa.

Agnes Elangwe, Jean-Claude Katte, Donald Tchapmi, Albert Figueras, Jean Claude Mbanya

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Agnes ElangweEu2P European Programme in Pharmacovigilance and Pharmacoepidemiology, Université Bordeaux-Segalen, Bordeaux, France.ORCID https://orcid.org/0000-0002-0804-5137
Jean-Claude KatteNational Obesity Center and Endocrinology and Metabolic Diseases Unit, Yaoundé Central Hospital, Yaounde, Cameroon.ORCID https://orcid.org/0000-0001-5631-2810
Donald TchapmiNgoulemedouka District Hospital, Ngoulemedouka, Cameroon.ORCID https://orcid.org/0000-0002-6483-5758
Albert FiguerasEu2P European Programme in Pharmacovigilance and Pharmacoepidemiology, Université Bordeaux-Segalen, Bordeaux, France.ORCID https://orcid.org/0000-0002-2740-2013
Jean Claude MbanyaNational Obesity Center and Endocrinology and Metabolic Diseases Unit, Yaoundé Central Hospital, Yaounde, Cameroon. jcmbanya@yahoo.co.uk.ORCID https://orcid.org/0000-0001-9651-8653
Central Hospital of Yaoundé · CMUniversitat Autònoma de Barcelona · ESUniversité de Bordeaux · FRUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe study aimed to identify and describe adverse drug reactions and adherence to clinical guidelines in patients receiving treatment for type 2 diabetes mellitus (T2DM) in Cameroon.

methodsThe method used was a cross-sectional study at a tertiary diabetes care service in Yaoundé, Cameroon. Adult T2DM patients attending the diabetes clinic were interviewed using a pre-structured data collection form. Adverse drug reactions (ADRs) were self-reported by the patients. Naranjo's algorithm and Hartwig and Siegel's scale were used for assessment of causality and severity of ADRs, respectively. A blinded senior endocrinologist assessed whether treatment pattern of patients was "adherent" or not to local clinical guidelines for the management of diabetes.

resultsOf a total of 350 patients enrolled into the study 61.1% were on oral hypoglycaemic agents only, 24.9% were on both oral hypoglycaemic agents and insulin, while 13.4% were on insulin alone. Metformin was used by 96.3% of the patients. Ninety patients reported 101 suspected ADRs. The proportion of ADRs among patients with poor adherence to clinical guidelines was higher than ADRs reported among adherent patients (Chi-square test = 7.3273; p = 0.007). Hypoglycaemia was more frequent ADR among non-adherent (25.7% of the suspected ADR) than adherent participants (11.6%). In the participants whose treatment pattern did not adhere to local clinical guidelines, ADRs were definite in 63.9%, probable in 16.6%, doubtful in 13.9% and possible in 5.6% of the cases. ADRs were moderate in 61.1% and severe in 19.4% of cases whose treatment pattern was non-adherent to clinical guidelines.

interpretationAdverse drug reactions may be frequent in type 2 diabetes patients whose treatment pattern does not adhere to local clinical guidelines in Cameroon. Therefore, the promotion of active pharmacovigilance and the design of training activities to promote the appropriate use of medicines at hospital level in Cameroon could help to improve the management of diabetes and reduce the incidence of avoidable ADRs in the future.

Indexed as

Guideline AdherenceAdultAgedCross-Sectional StudiesDiabetes Mellitus, Type 2Drug-Related Side Effects and Adverse ReactionsFemaleHumansHypoglycemic AgentsMaleMiddle AgedPharmacovigilanceTertiary Health CareHypoglycemic AgentsCameroonDrug utilization studyEndocrinologyPharmacovigilance

Identifiers

PMID32607780
OpenAlexW3039310006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.